GlycoEra

Series-B+
glycoera.com Biotech & Healthcare Wädenswil, Switzerland Founded 2021 11-50
Total Funding $179M
Latest Round $130M Series-B+
Last Announced May 27, 2025
Investors 12 Backers
Decision Makers 5 Verified

About GlycoEra

GlycoEra develops biologics to selectively degrade specific circulating proteins that drive autoimmune diseases. Its platform designs therapeutics to target disease-causing proteins like autoantibodies. The company aims to improve patient outcomes by enabling earlier intervention in autoimmune conditions.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Wädenswil, Switzerland
Year Founded 2021
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website glycoera.com
Domain Registered Date Mar 5, 2020

Social & Network Presence

X / Twitter Profile @glycoera (11 followers) Created on Nov 2020
LinkedIn Corporate Not linked

Company Milestones & Timeline

5 Events
  1. Capital Raise

    Raised $130,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $49,000,000 · Series-A

  3. Milestone

    Company founded

    Wädenswil, Switzerland

  4. Milestone

    X account created (@glycoera)

    11 followers

  5. Milestone

    Website domain registered

    glycoera.com

Investors & Backers

12
5AM Ventures
Agent Capital
Bristol-Myers Squibb
Catalio
LifeArc Ventures
LimmaTech Biologics
MP Healthcare Venture Management
Novo Holdings
Qatar Investment Authority
Roche Venture Fund
Sixty Degree Capital
Sofinnova Partners

Funding History

2 Rounds
Series-B+ · May 27, 2025
Series-A · Nov 5, 2021
$49,000,000 Source

Founders & Leadership

7

Amir Faridmoayer

Founder

Work email & phone locked Unlock →

Dominique N. Sirena

Founder

Work email & phone locked Unlock →

Ganesh Kaundinya

President and CEO

Work email & phone locked Unlock →

Greg Fralish

Chief Business Officer

Work email & phone locked Unlock →

Petra Duda

Chief Medical Officer

Work email & phone locked Unlock →

Tanmoy Ganguly

Chief Scientific Officer

Work email & phone locked Unlock →

Veronica Gambillara Fonck

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts